Onychomycosis: Old and New
- PMID: 37233270
- PMCID: PMC10219498
- DOI: 10.3390/jof9050559
Onychomycosis: Old and New
Abstract
Onychomycosis is a common chronic fungal infection of the nail that causes discoloration and/or thickening of the nail plate. Oral agents are generally preferred, except in the case of mild toenail infection limited to the distal nail plate. Terbinafine and itraconazole are the only approved oral therapies, and fluconazole is commonly utilized off-label. Cure rates with these therapies are limited, and resistance to terbinafine is starting to develop worldwide. In this review, we aim to review current oral treatment options for onychomycosis, as well as novel oral drugs that may have promising results in the treatment of onychomycosis.
Keywords: dermatophyte; dermoscopy; fungal culture; fungal nail infection; nondermatophyte; onychomycosis; yeast.
Conflict of interest statement
A.T. is a consultant for DS Laboratories, Monat Global, Almirall, Thirty Madison, Eli Lilly, Bristol Myers Squibb, P&G, Pfizer, and Myovant. The remaining authors have no conflicts to declare. We confirm that neither the manuscript nor any parts of its content are currently under consideration or published in another journal.
References
-
- Gupta A.K., Gupta G., Jain H.C., Lynde C.W., Foley K.A., Daigle D., Cooper E.A., Summerbell R.C. The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30000 patients visiting physicians’ offices. J. Eur. Acad. Dermatol. Venereol. 2016;30:1567–1572. doi: 10.1111/jdv.13677. - DOI - PubMed
-
- Gupta A.K., Jain H.C., Lynde C.W., Watteel G.N., Summerbell R.C. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists’ offices in Ontario, Canada—A multicenter survey of 2001 patients. Int. J. Dermatol. 1997;36:783–787. doi: 10.1046/j.1365-4362.1997.00349.x. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical